Meidan Ying
Ministry of Education of the People's Republic of China(CN)Interface (United States)(US)Zhejiang Cancer Hospital(CN)Children's Hospital of Zhejiang University(CN)Zhejiang Lab(CN)Pharmaceutical Biotechnology (Czechia)(CZ)Hangzhou City UniversityHuazhong University of Science and Technology(CN)Zhejiang University(CN)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Retinoids in leukemia and cellular processes, Cancer, Hypoxia, and Metabolism, Acute Myeloid Leukemia Research, RNA modifications and cancer
Most-Cited Works
- → DJ-1 suppresses ferroptosis through preserving the activity of S-adenosyl homocysteine hydrolase(2020)240 cited
- → USP10 Promotes Proliferation of Hepatocellular Carcinoma by Deubiquitinating and Stabilizing YAP/TAZ(2020)208 cited
- → Identification of PRDX6 as a regulator of ferroptosis(2019)159 cited
- → All-Trans Retinoic Acid Prevents Osteosarcoma Metastasis by Inhibiting M2 Polarization of Tumor-Associated Macrophages(2017)154 cited
- → Discovery of a first-in-class CDK2 selective degrader for AML differentiation therapy(2021)154 cited
- → LncRNA-MM2P Identified as a Modulator of Macrophage M2 Polarization(2018)153 cited